PG Stock DD Procter & Gamble Co. (The) Sunday, April 27, 2014

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
PG Procter & Gamble Co. (The) $PG Company Overview

Stock Message Board http://investorshangout.com/search?q=PG&t...mp;yt1=Go!

Last Updated: Sunday, April 27, 2014 9:15:39 PM

Procter & Gamble Co. (The) PG Current Price and Quotes
Last Price 81.41
Previous Close 81.15 Open 81.20
Daily Range 80.97 - 81.58 52wk Range 73.61 - 85.82
Volume 7,497,404 Dividend 2.5744
Average Vol (3m) 9,212,005 Yield 3.1623
Procter & Gamble Co. (The) PG

Procter & Gamble Co. (The) PG
Procter & Gamble Co. (The) PG

Procter & Gamble Co. (The) PG


Procter & Gamble Co. (The) PG Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 84,167,000 83,680,000 81,104,000 77,567,000
Cost of Revenue 42,428,000 42,391,000 39,859,000 37,042,000
Gross Profit 41,739,000 41,289,000 41,245,000 40,525,000
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 26,950,000 26,421,000 25,750,000 24,793,000
Non-Recurring Items 308,000 1,576,000 - -
Other - - - -
Operating Income 14,481,000 13,292,000 15,495,000 15,732,000
Income From Continuing Operations

Add'l Income/Expense Items 1,029,000 262,000 333,000 82,000
Earnings Before Interest and Tax 15,510,000 13,554,000 15,828,000 15,814,000
Interest Expense 667,000 769,000 831,000 946,000
Earnings Before Tax 14,843,000 12,785,000 14,997,000 14,868,000
Income Tax 3,441,000 3,468,000 3,299,000 4,017,000
Minority Interest 90,000 148,000 130,000 110,000
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 11,402,000 9,317,000 11,698,000 10,851,000
Non Recurring Events

Discontinued Operations - 1,587,000 229,000 1,995,000
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 11,312,000 10,756,000 11,797,000 12,736,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 11,312,000 10,756,000 11,797,000 12,736,000

Procter & Gamble Co. (The) PG Recent News

PG Procter & Gamble Co. (The) Research DD Guide

Stock Message Board http://investorshangout.com/search?q=PG&t...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/PG/quote
Stock Chart http://www.otcmarkets.com/stock/PG/chart
Company Info http://www.otcmarkets.com/stock/PG/company-info
Recent News http://www.otcmarkets.com/stock/PG/news
Financials http://www.otcmarkets.com/stock/PG/financials
Filings and Disclosure http://www.otcmarkets.com/stock/PG/filings
Short Sales http://www.otcmarkets.com/stock/PG/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/PG/insider-transactions
Research Reports http://www.otcmarkets.com/stock/PG/research
Summary http://finance.yahoo.com/q?s=PG
Historical Prices http://finance.yahoo.com/q/hp?s=PG+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=PG
Basic Chart http://finance.yahoo.com/q/bc?s=PG+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PG+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=PG+Headlines
Press Releases http://finance.yahoo.com/q/p?s=PG+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=PG+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=PG+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=PG+Industry
Major Holders http://finance.yahoo.com/q/mh?s=PG+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=PG+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=PG+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=PG
Balance Sheet http://finance.yahoo.com/q/bs?s=PG
Cash Flow http://finance.yahoo.com/q/cf?s=PG+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/PG
Market Watch http://www.marketwatch.com/investing/stock/PG
Bloomberg http://www.bloomberg.com/quote/PG:US
Morningstar http://quotes.morningstar.com/stock/s?t=PG
Bussinessweek http://investing.businessweek.com/research/st...?ticker=PG
Barchart http://www.barchart.com/quotes/stocks/PG
OTC Short Report http://otcshortreport.com/index.php?index=PG
Investopedia http://www.investopedia.com/markets/stocks/PG/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 37

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 34

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

FuboTV Prepares for Q3 2024 Financial Results Release

Updated Category News Views 101

FuboTV to Reveal Q3 2024 Financial Insights FuboTV Inc. (d/b/a Fubo) (NYSE: FUBO), a prominent player in the sports streaming arena, has announced a significant event on the horizon. They will release their third quarter financial results for 2024 early in the market day, a move that provides a valuable update for investors and followers alike. Details about the Financial...

Continue Reading
Coinbase's Gokul Rajaram's Share Sale Highlights Market Trends

Updated Category News Views 262

Gokul Rajaram of Coinbase Sells Shares Recently, Gokul Rajaram, a director at Coinbase Global, Inc. (NASDAQ:COIN), made headlines by selling shares worth $64,536. This transaction took place in September, when he sold 400 shares at a price of $161.34 each. Such moves often attract a lot of attention from those tracking the cryptocurrency market and its developments...

Continue Reading
Robinhood's New Fund Unlocks Private AI Investments for All

Updated Category News Views 200

Robinhood Ventures' Bold Move Into Private AI Investments Robinhood Markets Inc. (NASDAQ: HOOD) is set to revolutionize the investment landscape by giving retail investors access to private startups focused on artificial intelligence (AI). Despite widespread chatter about a potential bubble in the AI sector, the company is moving forward with this innovative approach....

Continue Reading
IRG, PREP, and DWREP Join Forces for Major Site Redevelopment

Updated Category News Views 184

Investment in Future Growth In an exciting development, Industrial Realty Group, LLC (IRG), along with Provider Real Estate Partners (PREP) and DW Real Estate Partners, LLC (DWREP), have embarked on a significant project to redevelop an industrial property in Ohio. The trio has successfully acquired the Hilliard Commerce Center, a sprawling 177,680 square-foot facility...

Continue Reading
Understanding Publicis Groupe’s Recent Share Trading Activity

Updated Category News Views 149

Overview of Share Trading Activities Publicis Groupe recently engaged in notable share trading activities, reflecting its strategic moves in the market. This trading involves shares acquired as part of a pre-approved program by the company's shareholders, aimed at enhancing its capital management. Transaction Details During the latest trading window, Publicis Groupe...

Continue Reading